Facebook
Twitter
Telegram
Report an ErrorCNS Pharmaceuticals Financial Statements 2011-2024 | CNSP
Annual Financial Statements CNS Pharmaceuticals
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
1.32 M | 1.54 M | 528 K | 28.4 M | 59.4 M | - | - | - | - | - | - | - | - |
Shares |
3.77 M | 1.36 M | 878 K | 16.5 M | 13.6 M | - | - | - | - | - | - | - | - |
Historical Prices |
0.35 | 1.13 | 0.601 | 1.72 | 4.31 | - | - | - | - | - | - | - | - |
Net Income |
-18.9 M | -15.3 M | -14.5 M | -9.46 M | -3.88 M | -7.39 M | - | - | - | - | - | - | - |
Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-18.9 M | -15.3 M | -14.5 M | -9.45 M | -3.83 M | -882 K | - | - | - | - | - | - | - |
Interest Expense |
13.8 K | 7.03 K | 9.28 K | 3.26 K | 26.2 K | 28.6 K | - | - | - | - | - | - | - |
EBITDA |
-18.9 M | -15.3 M | -14.5 M | -9.44 M | -3.83 M | -7.35 M | - | - | - | - | - | - | - |
Operating Expenses |
18.9 M | 15.3 M | 14.5 M | 9.45 M | 3.83 M | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
4.77 M | 5.97 M | 4.68 M | 4.39 M | 1.98 M | 861 K | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Income Statement CNS Pharmaceuticals
| 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
4.18 M | 3.88 M | 1.91 M | 1.62 M | 1.33 M | 1.33 M | 1.29 M | 27.9 M | 27.4 M | 25.4 M | 24.7 M | 23.9 M | 16.5 M | 16.5 M | 16.5 M | 16.5 M | 13.6 M | 13.2 M | 12.7 M | 16.5 M | 10.5 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income |
-4.52 M | -4.02 M | -4.93 M | - | -3.42 M | -3.57 M | -3.15 M | - | -3.81 M | -3.81 M | -3.61 M | - | -2.01 M | -2.47 M | -1.97 M | - | -707 K | -432 K | -212 K | - | -193 K | -257 K | -310 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
- | - | - | - | 76.1 K | 65.8 K | 48.7 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-4.53 M | -4.03 M | -4.93 M | - | -3.42 M | -3.56 M | -3.15 M | - | -3.81 M | -3.81 M | -3.61 M | - | -2.01 M | -2.47 M | -1.97 M | - | -699 K | -415 K | -195 K | - | -170 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Interest Expense |
1.84 K | 3.65 K | 5.44 K | - | 538 | 1.61 K | 2.57 K | - | 947 | 2.35 K | 3.75 K | - | - | - | - | - | 7.56 K | 7.48 K | 7.49 K | - | 10.6 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
- | - | -4.93 M | - | -3.41 M | -3.56 M | -3.15 M | - | -3.8 M | -3.81 M | -3.61 M | - | -2 M | -2.47 M | -1.97 M | - | -698 K | -415 K | -195 K | - | -170 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Expenses |
4.53 M | 4.03 M | 4.93 M | - | 3.42 M | 3.56 M | 3.15 M | - | 3.81 M | 3.81 M | 3.61 M | - | 2.01 M | 2.47 M | 1.97 M | - | 699 K | 415 K | 195 K | - | 170 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
1.12 M | 1.18 M | 1.36 M | - | 1.21 M | 1.34 M | 1.26 M | - | 1.24 M | 1.15 M | 1.4 M | - | 969 K | 981 K | 1.36 M | - | 373 K | 372 K | 147 K | - | 165 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency